ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Real Botanicals Launches Mindless Microdose Mushroom Tablets: Precision Microdosing for Elevated Creativity and Calm Focus


Charlotte, North Carolina – December 29, 2025 – Real Botanicals, a leader in premium plant-based wellness products known for its innovative ChromaPure extraction and lab-verified kratom and kava products, today announced the launch of Mindless Microdose Mushroom Tablets. 

This new product delivers a clean, consistent microdose of the proprietary Mindless Mushroom Blend, designed to quiet mental noise, spark creativity, and foster presence without the mess of gummies or the uncertainty of traditional methods.​

Product Innovation and Key Features

Mindless Microdose Mushroom Tablets stand out with their splittable design, providing two 2.5 mg servings per 5 mg tablet for precise user control. Available in convenient 4-count and 10-count packs with a refreshing Blue Raspberry flavor, these vegan and gluten-free tablets require no mixing, offer fast-acting effects, and ensure long-lasting benefits in a portable and discreet format. 

Unlike sugary gummies with inconsistent potency and slow absorption, Mindless mushroom offers a pure formula free from fillers, additives, and sugar highs, delivering elevated vibes and mental clarity on demand.

The tablets feature a pharmaceutical-grade microcrystalline base for even distribution and stable absorption, interacting subtly with serotonin 5-HT₂A receptors to enhance mood, focus, and sensory perception at microdose levels without hallucinations or distortion. 

Users report a smooth onset in 30-60 minutes, lasting 4-6 hours, with effects like emotional lightness, creative flow, calm productivity, and a gentle return to baseline.

Superiority Over Mushroom Gummies

This comparison highlights why users switch to Mindless for predictable, clean experiences tailored to modern lifestyles.

Safety, Quality, and Suggested Use

Certified third-party lab testing confirms the purity, potency, and absence of contaminants, including yeast, mold, heavy metals, and pathogens. Start with ½ tablet (2.5 mg), wait 30-60 minutes, and do not exceed two tablets daily. 

Store in a cool, dry place. While not evaluated by the FDA and not intended to diagnose, treat, cure, or prevent any disease. Mindless mushroom tablets prioritize safety, and it's not for minors, those with addiction history, or without physician consultation if needed.

Target Audience and Real User Testimonials

Crafted for creatives, biohackers, wellness seekers, and microdosing beginners, Mindless fits morning rituals, creative sessions, or mindful recalibration.

Everything just clicked… light, focused, and creative without overwhelm,” shares Riley J. “Mindless helped break my creative rut and be present,” adds Maya K. 

Way cleaner and more predictable than gummies,” notes Jordan T.

About Real Botanicals

Founded in 2021 with a facility in South Carolina, Real Botanicals redefines botanicals through its owned labs, ethical sourcing, and innovation in kratom, kava, and now microdose mushrooms. Committed to quality, the brand empowers natural wellness.

Mindless Microdose Mushroom Tablets are available now at https://realbotanicals.com/products/mindless-microdose-mushroom-tablets. 

As the brand says, experience clarity without chaos. Don’t overthink it - try Mindless today. 


Recent Quotes

View More
Symbol Price Change (%)
AMZN  245.65
-0.64 (-0.26%)
AAPL  258.37
-0.67 (-0.26%)
AMD  205.02
+0.34 (0.17%)
BAC  56.05
-0.13 (-0.24%)
GOOG  329.18
+3.17 (0.97%)
META  651.35
+5.29 (0.82%)
MSFT  476.23
-1.88 (-0.39%)
NVDA  184.95
-0.09 (-0.05%)
ORCL  197.41
+8.25 (4.36%)
TSLA  448.57
+12.77 (2.93%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.